Binance Labs has announced its investment in BIO Protocol, marking its initial venture into the decentralized science (DeSci) sector. The investment aligns Binance Labs with other Web3 entities, such as A16z and Coinbase CEO Brian Armstrong, who are exploring DeSci. BIO Protocol aims to revolutionize the funding and commercialization of early-stage scientific research using blockchain technology, likened to a "Y Combinator for on-chain Science." The project has raised $13 million to date, with its network comprising seven DAOs on the Ethereum blockchain, focusing on diverse research areas.